Iveda Announces Pricing of $2 Million Public Offering
Rhea-AI Summary
Iveda (Nasdaq: IVDA) priced a public offering of 5,714,286 common shares (or pre-funded warrants) plus series X warrants to buy up to 11,428,572 shares at a combined public offering price of $0.35 per share with accompanying warrants.
The series X warrants are exercisable immediately, expire in two years, and the offering is expected to close on or about February 11, 2026, with gross proceeds of approximately $2.0 million before fees. The registration statement was declared effective on February 9, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- Gross proceeds of approximately $2.0 million
- Proceeds available for general corporate purposes
- Series X warrants exercisable immediately
Negative
- Issuance of shares and warrants may cause shareholder dilution
- Offering priced at $0.35 per share could pressure market valuation
- Net proceeds reduced by placement agent fees and offering expenses
News Market Reaction – IVDA
On the day this news was published, IVDA declined 34.64%, reflecting a significant negative market reaction. Argus tracked a peak move of +9.2% during that session. Argus tracked a trough of -55.2% from its starting point during tracking. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $1M from the company's valuation, bringing the market cap to $2.68M at that time. Trading volume was exceptionally heavy at 16.9x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Offering Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Sep 05 | Equity offering | Negative | -25.6% | Registered direct equity raise with shares and warrants priced at-the-market. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior equity offerings for IVDA have coincided with sharp negative reactions, with the last tagged offering moving the stock -25.62% the following day.
The most relevant history for this offering is IVDA’s September 5, 2024 registered direct deal, where the company raised $2.15 million by issuing 5,000,000 shares (or pre-funded warrants) at $0.43, plus Series A and B warrants for up to 10,000,000 additional shares. That financing, arranged through H.C. Wainwright and linked to a shelf registration, saw the stock fall 25.62% over the next 24 hours, suggesting a history of weak price responses to dilution events.
Historical Comparison
IVDA’s last tagged offering on Sep 5, 2024 raised $2.15M and led to a -25.62% move, underscoring a pattern of sharp selloffs around equity financings.
Recent financing history shows repeated capital raises using common stock, pre-funded warrants and series warrants under an existing shelf structure.
Regulatory & Risk Context
IVDA has an effective S-3 resale registration for up to 1,296,876 warrant shares at exercise prices of $3.44 and $4.30. The company would receive up to $4.4 million only if these warrants are exercised for cash; the filing itself involves selling stockholders and does not provide new primary proceeds.
Key Terms
pre-funded warrants financial
series X warrants financial
public offering financial
registration statement on Form S-1 regulatory
prospectus regulatory
Securities and Exchange Commission regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Iveda® (Nasdaq: IVDA), the global leader in AI video surveillance and smart city solutions, today announced the pricing of a public offering of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) and series X warrants to purchase up to 11,428,572 shares of its common stock, at a combined public offering price of
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The gross proceeds to the Company from the offering are expected to be approximately
A registration statement on Form S-1 (File No. 333-293126) relating to the public offering was declared effective by the Securities and Exchange Commission (the “SEC”) on February 9, 2026. The public offering is being made only by means of a prospectus forming part of the effective registration statement relating to the public offering. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About Iveda Solutions®
Iveda (NASDAQ: IVDA) is the provider of global solutions for cloud-based, video AI search and surveillance technologies that protect the people, places, and things that matter the most. Iveda’s technology provides instant intelligence to existing infrastructure, enabling cities and organizations around the world to seamlessly enter the fifth industrial revolution. Headquartered in Mesa, Arizona, with a subsidiary in Taiwan, Iveda is publicly traded under the ticker symbol “IVDA.”
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including, without limitation, statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the “Risk Factors” in the prospectus included in our registration statement on Form S-1 for a comprehensive understanding. Iveda undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release, except as required by applicable laws or regulations.
Media Contact
Olivia Civiletto Erwin
olivia@dottedlinecomm.com
716.785.1108
